TEVA Director Zaks Tal Zvi Sells 17 Shares

What Happened Zaks Tal Zvi, a director of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 17 ordinary shares in an open-market transaction on August 5, 2026, at $34.87 per share, for total proceeds of approximately $593. The sale was reported on a Form 4 filed on August 10, 2026. Sales by insiders are commonly routine transactions and do not necessarily indicate a change in company outlook.

Key Details

• Transaction date: August 5, 2026; Price: $34.87 per share; Quantity: 17 shares; Proceeds: ~$592.79 (rounded to $593).
• Filing date: Form 4 filed August 10, 2026 (filed five days after the transaction); this appears to be later than the typical two-business-day Form 4 reporting requirement.
• Shares owned after transaction: not specified in the filing excerpt provided.
• Footnote: F1 notes the ordinary shares may be represented by American Depositary Shares (each currently represents one Ordinary Share).
• No 10b5-1 plan, option exercise, gift, or tax-withholding notation is indicated in the provided transaction details.

Context This was a small-value open-market sale (under $1,000) by a company director. Such modest disposals are often routine and should be weighed accordingly by retail investors; they do not provide strong evidence of insider sentiment on their own.